The all-stock $18 billion merger between Towers Watson and Willis Group Holdings is a bad deal — according to some Towers Watson shareholders.

Also see: What does the Willis, Towers Watson merger mean about the health care industry?

Register or login for access to this item and much more

All Employee Benefit Adviser content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access